<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Antithrombin III is the major physiological inhibitor of the coagulation mechanism and a deficiency of this protein results in a marked predisposition to venous <z:hpo ids='HP_0001907'>thromboembolic disease</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Three Scottish families with a deficiency of this protein are described and other reported families are reviewed </plain></SENT>
<SENT sid="2" pm="."><plain>The properties, functions and methods of assay of antithrombin III are outlined; the molecular abnormalities, <z:hpo ids='HP_0000005'>inheritance</z:hpo>, clinical and laboratory characteristics of <z:hpo ids='HP_0001976'>antithrombin III deficiency</z:hpo> are described, and the use of antithrombotic drugs and human antithrombin III concentrates in this deficiency is discussed </plain></SENT>
</text></document>